Results 31 to 40 of about 6,653 (246)

Mini-Review: Human Microbiome and Rheumatic Diseases

open access: yesFrontiers in Cellular and Infection Microbiology, 2020
Rheumatoid arthritis and spondyloarthropathy are the most common inflammatory rheumatic diseases. As the human microbiome is involved in the immune homeostasis, it has the potential to be a key factor in the development of autoimmune diseases and ...
Meltem Vural   +4 more
doaj   +1 more source

Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis [PDF]

open access: yes, 2009
OBJECTIVE: Subclinical gut inflammation is common in spondylarthritis, but the immunologic abnormalities underlying this process are undefined. Perturbation of the interleukin-23 (IL-23)/Th17 axis has emerged as a fundamental trigger of chronic ...
Becker   +40 more
core   +1 more source

MRI changes in psoriatic dactylitisextent of pathology, relationship to tenderness and correlation with clinical indices [PDF]

open access: yes, 2008
Objectives. To quantify the extent of inflammation in psoriatic dactylitis and to examine the relationship between clinical and magnetic resonance imaging (MRI) data in both tender and non-tender dactylitis. Methods.
Chandramohan, M.   +3 more
core   +1 more source

MRI Findings in Axial Psoriatic Spondylarthritis

open access: yesDiagnostics, 2023
Psoriatic arthritis is a significant medical condition with a high prevalence, a wide variety of non-specific symptoms, and a high degree of overlap with other spondylarthritis disorders, particularly ankylosing spondylitis.
Loredana Sabina Pascu   +8 more
doaj   +1 more source

Inflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes [PDF]

open access: yes, 2016
Background\ud \ud Ankylosing spondylitis (AS) is an immune-mediated arthritis particularly targeting the spine and pelvis and is characterised by inflammation, osteoproliferation and frequently ankylosis.
Allan F. McRae   +7 more
core   +4 more sources

Histocompatibility HLA class I in anterior uveitis patients with and without spondyloarthritis

open access: yesСовременная ревматология, 2018
Anterior uveitis (AU) and ankylosing spondylitis (AS) are associated with histocompatibility human leukocyte antigen (HLA)-B27. Previous genetic studies conducted in different populations have also demonstrated other genetic associations, including HLA ...
I. A. Guseva   +2 more
doaj   +1 more source

Persistencia de medicamentos biológicos durante ocho años en pacientes con artritis reumatoide y espondiloartritis [PDF]

open access: yes, 2019
Objective: To calculate the persistence, over a period of eight years, the retention rate of first and second-line of treatment with biological agents in patients with rheumatoid arthritis, spondyloarthritis and psoriatic arthritis and to compare ...
Balsa, Alejandro   +5 more
core   +3 more sources

Chronic pyogenic spondylitis in patients with spinal gout: a case series and literature review [PDF]

open access: yesTravmatologiâ i Ortopediâ Rossii
Background. Spinal gout is a rare and poorly described group of noninfectious inflammatory spinal lesions characterized by the deposition of monosodium urate crystals in the epidural space, paravertebral soft tissues, and by facet joints damage. There is
Arkadiy A. Vishnevskiy   +3 more
doaj   +1 more source

Physical activity and sedentary behaviour and their associations with clinical measures in axial spondyloarthritis [PDF]

open access: yes, 2019
Engaging in physical activity (PA) is a key aspect in the management of axial spondyloarthritis (axial SpA), however, its relationship with clinical measures is unknown.
Cameron, Sara   +4 more
core   +3 more sources

Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients [PDF]

open access: yes, 2009
INTRODUCTION: Reactivation of hepatitis B virus (HBV) infection in patients with past infection has been described in 5% to 10% of individuals undergoing immunosuppressive therapies.
Benoit Thomachot   +9 more
core   +2 more sources

Home - About - Disclaimer - Privacy